Advertisement
Singapore markets close in 6 hours 41 minutes
  • Straits Times Index

    3,309.90
    +2.00 (+0.06%)
     
  • Nikkei

    38,841.06
    +223.96 (+0.58%)
     
  • Hang Seng

    18,835.40
    -360.20 (-1.88%)
     
  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     
  • Bitcoin USD

    69,506.76
    -698.38 (-0.99%)
     
  • CMC Crypto 200

    1,510.92
    -15.49 (-1.02%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • Dow

    39,671.04
    -201.95 (-0.51%)
     
  • Nasdaq

    16,801.54
    -31.08 (-0.18%)
     
  • Gold

    2,373.40
    -19.50 (-0.81%)
     
  • Crude Oil

    76.95
    -0.62 (-0.80%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • FTSE Bursa Malaysia

    1,631.00
    +8.91 (+0.55%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,618.57
    +11.35 (+0.17%)
     

U.S. Physical Therapy First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

U.S. Physical Therapy (NYSE:USPH) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$154.0m (up 4.8% from 1Q 2023).

  • Net income: US$6.98m (down 7.0% from 1Q 2023).

  • Profit margin: 4.5% (down from 5.1% in 1Q 2023).

  • EPS: US$0.46 (down from US$0.58 in 1Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

U.S. Physical Therapy Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 22%.

Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US.

ADVERTISEMENT

Performance of the American Healthcare industry.

The company's shares are up 2.3% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 5 warning signs for U.S. Physical Therapy you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.